ArticleFuture oncology (London, England)2025

Second line advanced or metastatic non-small cell lung cancer treatment after chemo-immunotherapy: a retrospective study.

Lyudmila Bazhenova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.